We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
Helping public health practitioners conducting evaluations – using process evaluations to explain how complex interventions work.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
What you need to know before you can place a medical device on the Great Britain market with a UKCA mark.
Helping public health practitioners conducting evaluations – what the evaluation is, when it should be undertaken and the different types of evaluation available.
This service allows hospitals to record incidents of infection after surgery, track patient results and review or change practice to avoid further infections.
The process for applicants applying for a Paediatric Investigation Plan (PIP) modification or waiver.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
How developers can get their health app assessed and endorsed.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Help available and steps you should take if you have a medical emergency or are hospitalised abroad, including for planned treatment.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Information about the EU Regulations and their implementation in Northern Ireland
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.